Chemotherapy before surgery for bladder cancer
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial looks at whether giving chemotherapy before surgery helps people with muscle invasive bladder cancer live longer. It is for patients who haven't had surgery yet and whose cancer hasn't spread.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with muscle invasive bladder cancer (cancer that has grown into the bladder muscle).
- You have received platinum-based chemotherapy before any surgery for your bladder cancer.
- Your cancer has not spread to other parts of the body (metastatic).
- You did not have surgery to remove the bladder or tumor before starting chemotherapy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 trial studies giving cisplatin-based chemotherapy before surgery for certain newly diagnosed upper-urinary-tract urothelial cancers (kidney/ureter). It may help shrink the cancer and improve outcomes by treating microscopic disease earlier.
This trial tests a dense schedule of two chemotherapy drugs (gemcitabine and cisplatin) given before bladder removal surgery. It aims to shrink the tumor and improve outcomes for people with bladder cancer that has grown into the muscle layer.
This trial tests two immunotherapy drugs given before bladder/urinary tract cancer surgery. It aims to shrink the tumor and improve outcomes in people who cannot safely take cisplatin chemotherapy.
This study looks at how well MRI scans can detect bladder cancer after chemotherapy, before surgery to remove the bladder. It may help doctors know if the chemo is working.
This trial tests whether giving chemotherapy immediately after surgery can help people with high-risk, non-muscle-invasive bladder cancer. It aims to reduce the chance of the cancer coming back.
This trial compares two main treatments for muscle-invasive bladder cancer: radical cystectomy (surgery to remove the bladder) and a combination of chemotherapy and radiation (chemo-radiation). The goal is to see which approach is better for patients whose cancer has not spread widely.
Hear when a new Bladder Urothelial Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.